What does CUSIP 77313F106 represent in this 13F holders report?

CUSIP 77313F106 is the security identifier for RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in Q4 2020?

172 institutional investors reported RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock for Q4 2020. Use the holders table for investor-level position and value details.

ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock
Shares outstanding: 109,265,652
Total 13F shares: 61,952,909
Share change: +6,714,279
Total reported value: $3,397,683,589
Put/Call ratio: 159%
Price per share: $54.84
Number of holders: 172
Value change: +$431,615,785
Number of buys: 101
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 77313F106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	15%	16,812,491	$384,334,000	—	30 Sep 2020	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.7%	2,965,485	$67,791,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	2.6%	2,875,195	$65,728,000	—	30 Sep 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.2%	2,359,266	$53,933,000	—	30 Sep 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	2%	2,189,010	$50,041,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	1.8%	1,918,005	$43,844,000	—	30 Sep 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.5%	1,681,605	$38,441,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	1.5%	1,633,055	$37,332,000	—	30 Sep 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	1.5%	1,591,395	$36,379,000	—	30 Sep 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.4%	1,550,000	$35,433,000	—	30 Sep 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	1.4%	1,498,493	$34,256,000	—	30 Sep 2020	13F
Boxer Capital, LLC	13F	Company	1.3%	1,466,051	$33,514,000	—	30 Sep 2020	13F
Cormorant Asset Management, LP	13F	Company	1.3%	1,368,550	$31,285,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	1,127,600	$25,777,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	1%	1,111,809	$25,416,000	—	30 Sep 2020	13F
LOOMIS SAYLES & CO L P	13F	Company	0.99%	1,076,776	$24,615,000	—	30 Sep 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.98%	1,069,392	$24,446,000	—	30 Sep 2020	13F
Vivo Capital, LLC	13F	Company	0.79%	860,648	$19,674,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	0.74%	811,336	$18,547,000	—	30 Sep 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.61%	668,967	$15,292,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.49%	531,032	$12,139,000	—	30 Sep 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.48%	528,000	$12,070,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.41%	444,184	$10,155,000	—	30 Sep 2020	13F
Invesco Ltd.	13F	Company	0.38%	419,425	$9,588,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.38%	411,995	$9,419,000	—	30 Sep 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.37%	400,000	$9,144,000	—	30 Sep 2020	13F
Assenagon Asset Management S.A.	13F	Company	0.32%	344,729	$7,881,000	—	30 Sep 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.31%	343,012	$7,841,000	—	30 Sep 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.26%	280,964	$6,423,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.25%	277,296	$6,339,000	—	30 Sep 2020	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.24%	263,642	$6,027,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.23%	253,108	$5,786,000	—	30 Sep 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	234,455	$5,360,000	—	30 Sep 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.21%	228,016	$5,212,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.2%	218,970	$5,055,000	—	30 Sep 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.2%	219,879	$5,027,000	—	30 Sep 2020	13F
AXA S.A.	13F	Company	0.19%	212,186	$4,851,000	—	30 Sep 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.19%	210,683	$4,816,000	—	30 Sep 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.18%	193,626	$4,426,000	—	30 Sep 2020	13F
DSAM Partners (London) Ltd	13F	Company	0.16%	179,630	$4,106,000	—	30 Sep 2020	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	0.12%	134,310	$3,070,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	0.12%	128,229	$2,931,000	—	30 Sep 2020	13F
Samsara BioCapital, LLC	13F	Company	0.09%	99,643	$2,278,000	—	30 Sep 2020	13F
BARCLAYS PLC	13F	Company	0.09%	98,209	$2,245,000	—	30 Sep 2020	13F
Allianz Asset Management GmbH	13F	Company	0.08%	84,636	$1,934,000	—	30 Sep 2020	13F
Lisanti Capital Growth, LLC	13F	Company	0.08%	83,008	$1,898,000	—	30 Sep 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.07%	78,267	$1,789,000	—	30 Sep 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.07%	78,227	$1,788,000	—	30 Sep 2020	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.07%	73,700	$1,677,000	—	30 Sep 2020	13F
ALPS ADVISORS INC	13F	Company	0.06%	70,381	$1,609,000	—	30 Sep 2020	13F

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q4 2020

As of 31 Dec 2020, ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,952,909 shares. The largest 10 holders included RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, and LORD, ABBETT & CO. LLC. This page lists 172 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

124

Q4 2020 holders

172

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.